Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.34 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18802707 | 0.87 | ALDH1A1 (0.44) | ALDH1A1HSD11B1TSHRTDP1CYP3A4 | |
| SCHEMBL5807469 | 0.83 | ALDH1A1 (0.44) | ALDH1A1MAPK1HSD11B1TSHRTDP1 | |
| SCHEMBL1164219 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1HSD11B1TSHRTDP1 | |
| SCHEMBL30530486 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1HSD11B1TSHRTDP1 | |
| SCHEMBL18311678 | 0.81 | SLC22A12 (0.41) | ALDH1A1HSD11B1TSHRTDP1CYP3A4 | |
| SCHEMBL21102264 | 0.81 | PGR (0.38) | ALDH1A1MAPK1HSD11B1TSHRTDP1 | |
| SCHEMBL14096716 | 0.78 | ALDH1A1 (0.38) | ALDH1A1HSD11B1TSHRTDP1CYP3A4 | |
| SCHEMBL16547429 | 0.77 | KMT2A (0.39) | ALDH1A1MAPK1HSD11B1TDP1PDK2 | |
| SCHEMBL1590475 | 0.77 | ALDH1A1 (0.37) | ALDH1A1HSD11B1TSHRTDP1CYP3A4 | |
| SCHEMBL10094721 | 0.77 | GABRA1 (0.42) | ALDH1A1TSHRTDP1CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060223850-A1 | 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors | MERCK FROSST CANADA & CO. (CA) | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223850-A1 | 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors | PDE4A, PDE4B, PDE3B | ALDH1A1 408/4885MAPK1 1179/4885HSD11B1 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.